Drug class in one race
PD-L1 / VEGF drugs for Non-Small Cell Lung Cancer
3 tracked PD-L1 / VEGF drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PD-L1 / VEGF page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 32 Phase 2